The future looks very bullish for this vaccine specialist. At the beginning of 2020, Novavax (NASDAQ:NVAX) had a valuation of $4 a share. Six months later, the company's stock sells for $47 a share. That's a dramatic shift in perception of value. What's the stock market seeing now that it didn't see in January? In a…
Novavax is well ahead in clinical testing than two of the White House's COVID-19 vaccine finalists. No company has developed a COVID-19 vaccine that's been proven to be safe and effective yet. But several appear to be getting a big boost for their efforts from Uncle Sam. The New York Times reported on Wednesday that…
You don't have permission to access "http://www.medpagetoday.com/publichealthpolicy/opioids/121855" on this server. Reference #18.9177d917.1782144250.49648233 https://errors.edgesuite.net/18.9177d917.1782144250.49648233
-- OPINION -- A father named Chris George spent the better part of a year trying to answer a question that should not have been hard to answer: who grew and processed the lettuce that nearly killed his son? Colton George, now ten, was nine years old when he ate romaine contaminated with E. coli O157:H7 in
You don't have permission to access "http://www.medpagetoday.com/podcasts/healthwatch/121815" on this server. Reference #18.9177d917.1782043367.359d0f85 https://errors.edgesuite.net/18.9177d917.1782043367.359d0f85